Eli Lilly & Co.: The Indianapolis pharmaceuticals...
From Times Staff and Wire Reports
Eli Lilly & Co.: The Indianapolis pharmaceuticals maker reported record first-quarter sales of $1.44 billion, up 14% from the year-ago quarter. Revenue jumped 16% to a record $388.6 million. The company said a surge in sales in Europe and Japan was a key reason for the higher results.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
